Journal
ANNALS OF ONCOLOGY
Volume 21, Issue -, Pages 173-179Publisher
ELSEVIER
DOI: 10.1093/annonc/mdq295
Keywords
adverse effects; antineoplastic agents; arrhythmia; chemically induced heart diseases; heart failure; QTc prolongation
Categories
Ask authors/readers for more resources
Cancer treatment has improved extraordinarily in recent years. The development of targeted therapies has widened the cardiotoxic spectrum of antineoplastic drugs. Optimum management of cardiovascular disease before and during antineoplastic treatment is essential to reduce morbidity and mortality in cancer patients. This article reviews the incidence and characteristics of cardiotoxic effects of antineoplastic drugs with special focus on the pathophysiological mechanisms. It also emphasizes the importance of early detection and correction of cardiovascular risk factors and the relevance of close cardiac monitoring during antineoplastic treatment in order to reduce cardiotoxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available